Suppr超能文献

Org NC 45的临床评估。

Clinical evaluation of Org NC 45.

作者信息

Mirakhur R K, Ferres C J, Clarke R S, Bali I M, Dundee J W

出版信息

Br J Anaesth. 1983 Feb;55(2):119-24. doi: 10.1093/bja/55.2.119.

Abstract

Org NC 45, a new non-depolarizing neuromuscular blocking drug, was evaluated in 200 adult patients. The drug was administered in doses of 0.1, 0.15 or 0.2 mg kg-1. Intubation could be satisfactorily carried out at around 90 s in 90% of patients. The duration of clinical relaxation varied from 23 min with 0.1 mg kg-1 and neuroleptanaesthesia to 71 min with 0.2 mg kg-1 and anaesthesia with halothane or enflurane. The duration of clinical relaxation following repeated administration of 2-3 mg was remarkably constant (between 17 and 20 min) thus showing lack of cumulation. The antagonism of residual block was prompt and easy following administration of neostigmine, and the drug lacked any significant cardiovascular effects as seen by routine monitoring.

摘要

新型非去极化神经肌肉阻滞剂Org NC 45在200例成年患者中进行了评估。该药的给药剂量为0.1、0.15或0.2 mg/kg。90%的患者在约90秒时能顺利完成插管。临床肌肉松弛持续时间从0.1 mg/kg与神经安定麻醉合用的23分钟到0.2 mg/kg与氟烷或恩氟烷麻醉合用的71分钟不等。重复给予2 - 3 mg后临床肌肉松弛持续时间非常恒定(在17至20分钟之间),因此未显示出蓄积作用。新斯的明给药后,残余阻滞的拮抗迅速且容易,并且通过常规监测未发现该药有任何明显的心血管效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验